Fosamax Articles
Sanofi's Mid-term Pipeline "One Of The Most Promising
23 October 1995
New York Stock Comment
16 October 1995
USA Lags Foreign Approvals, PhRMA Demonstrates
16 October 1995
New York stock comment
9 October 1995
Merck's Fosamax Cleared For US Marketing
9 October 1995
Merck Sharp and Dohme launch Fosamax in UK
11 September 1995
Sandoz' Calcitonin Spray Approved
11 September 1995
NEW YORK STOCK COMMENT
24 July 1995
Merck's Fosamax Nears Market In USA
24 July 1995
Good Profits Performance Expected At Sanofi
24 July 1995
NEW YORK STOCK COMMENT
17 July 1995
Solid 2nd Qtr Earnings Growth For US Drugmakers
17 July 1995
Merck pipline report
3 July 1995
Merck gets Fosamax approval
3 July 1995
Merck's Fosamax Set For Rapid US Approval?
12 June 1995
NEW YORK STOCK COMMENT
6 March 1995
PH II RESULTS OF PROSCAR BALDNESS TRIALS
25 April 1994
TILUDRONATE EFFICACY SHOWN
4 April 1994
PREVENTION PRIORITIES FOR OSTEOPOROSIS
28 March 1994
MERCK FILES NDAs FOR COZAAR WORLDWIDE
21 February 1994
FOSAMIX INCREASES BONE DENSITY
27 September 1993
- Is failure to adopt business process management putting the pharma industry at risk?
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
